ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,393.80
0.85%
S&P ASX All Technology
3,840.60
-1.02%
Brent Oil
74.65
0.00%
US Dollar vs AUD
1.53846
0.00%
Bitcoin
98,317.65
0.54%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Bellevue Life Sciences Acquisition Corporation (BLAC) Share Price

Bellevue Life Sciences Acquisition Corporation

Bellevue Life Sciences Acquisition Corporation (BLAC)

NASDAQ
11.13
-0.49
(-4.22%)
Closed 24 November 8:00AM
Delayed by 15 minutes
11.13
0.00
(0.00%)
After Hours: 8:25AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
11.13
Bid
10.98
Offer
11.49
Volume
9,231
11.13 Day's Range 11.5695
10.43 52 Week Range 13.30
Market Cap
62.583M
Previous Close
11.62
Open
11.55
Last Trade
10
@
11.23
Last Trade Time
Financial Volume
US$ 104,486
VWAP
11.319
Average Volume (3m)
10,453
Shares Outstanding
5,622,954
Dividend Yield
-
PE Ratio
155.01
Earnings Per Share (EPS)
0.07
Revenue
-
Net Profit
404k

About Bellevue Life Sciences Acquisition Corporation

Bellevue Life Sciences Acquisition Corp is a blank check company. Bellevue Life Sciences Acquisition Corp is a blank check company.

Sector
Blank Checks
Industry
Blank Checks
Headquarters
Dover, Delaware, USA
Founded
-
Bellevue Life Sciences Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker BLAC. The last closing price for Bellevue Life Sciences A... was US$11.62. Over the last year, Bellevue Life Sciences A... shares have traded in a share price range of US$ 10.43 to US$ 13.30.

Bellevue Life Sciences A... currently has 5,622,954 shares in issue. The market capitalisation of Bellevue Life Sciences A... is US$65.34 million. Bellevue Life Sciences A... has a price to earnings ratio (PE ratio) of 155.01.

Ask ADVFN Intelligence (AI)

BLAC Latest News

More News

Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting

Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting PR Newswire BELLEVUE, Wash., May 13, 2024 BELLEVUE, Wash., May 13...

13 May 2024
PR Newswire (US)

/C O R R E C T I O N -- OSR Holdings/

/C O R R E C T I O N -- OSR Holdings/ PR Newswire SEOUL, South Korea, April 22, 2024 In the news release, OSR Holdings and SillaJen have entered into a Memorandum of Understanding to...

23 April 2024
PR Newswire (US)

OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market

OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market PR Newswire SEOUL, South...

22 April 2024
PR Newswire (US)

OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.

OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp. PR Newswire BELLEVUE, Wash. and SEOUL, South Korea, Nov. 16, 2023 BELLEVUE, Wash...

17 November 2023
PR Newswire (US)

Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination

Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination PR Newswire BELLEVUE, Wash. and SEOUL, South Korea, July 11, 2023 OSR...

12 July 2023
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.87-7.251213.311.13939311.79141765CS
40.181.6438356164410.9513.310.95574411.68675833CS
120.333.0555555555610.813.310.81045311.0422688CS
260.333.0555555555610.813.310.7731210.96554666CS
520.686.5071770334910.4513.310.431265310.73363032CS
1560.939.1176470588210.213.310.071638010.50676791CS
2600.939.1176470588210.213.310.071638010.50676791CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M

Discussion

View Full Feed
Truthsocial Truthsocial 8 minutes ago
Can someone who cares do a wellness check on sceeat...family members FDA or BIG Pharma please

Because RDGL and MAYO clinic are soon ready to move up in the outpatient cancer treatment world without sceeat....
RDGL
The ELTP King The ELTP King 9 minutes ago
This is my last post.

Taking a long break for the holidays.

Will return in early January.

Thanks.
ELTP
Murphydog25 Murphydog25 10 minutes ago
Just gave Hitman a DM to talk about this stock going forward so I'm feeling more positive now after his positive words of wisdom 🤗
He also said he's doing well but finding 6 by 6 a small space and his flatmate ron'da snores 🧐
NWPN
Azart Azart 23 minutes ago
My friend what Scamus is currently doing is absolutely not new. This is exactly how everything was transferred from the previous company to becoming Rannever Health back in 2014 or 15 if I am not mistaken. The back then CEO before Scamus did the exact same thing Scamus is doing with Foxo. Common hol
RNVA
SteveSchiets SteveSchiets 28 minutes ago
There was a lot of resistance not acting up on my belief S7 hasn't play it's final hand. The fact that ACC's are used by our competitors made me do that silly thing. Maybe also because other stocks in my portfolio needs more time, i decided to have one last go (it's never the last). If trillions wi
SEV
knrorrel knrorrel 1 hour ago
no chance in the quantum hype, $10 could come quickly now, like on Friday with qmco (+171%, only on Friday increased from $3.60 to $11!)

and it's a shame that they couldn't buy more,

but I feel the same way (I also have far too little of $QBTS but unfortunately I don'
QBTS
chen1992 chen1992 1 hour ago
https://youtu.be/PaMsc8z1Ls4?si=u3MwvbGovNMyWXI6


Inverse Cramer at it again! Did it for TELL!!!!
TGLO
silkmaster silkmaster 1 hour ago
It looks like we can only guss what would the pps will look like in a week/month or a year from now .
Mean while lets play what would the PPS look like come 30/11/24 so long as KT will come out and talk to the public by than that is ...

A. 0.09 (around current pps)
B. 0.
KBLB
ZLAZARUS ZLAZARUS 2 hours ago
Ph3 melanoma data for IO102-IO103 remain on track for 1H25 and represents the next key catalyst. At .70 we are trading at cash. With a positive Ph3 melanoma readout we will be trading at $3.00 overnight with a march to $6.00 towards the later half of 2025. In addition, I'm encouraged by the support
IOBT
knrorrel knrorrel 2 hours ago
https://de.tradingview.com/chart/Mq3nUQ7Y/?symbol=NYSE%3AQBTS
QBTS
knrorrel knrorrel 2 hours ago
friday +171% / $11 and $Q_BTS follows on Monday, which is much better than QMCO and still has a lot of potential to trade above $10 ?
all only imho

here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175432596


QMCO
Whalatane Whalatane 2 hours ago
Yes There will be less of a reaction in the UNCY stock for the reason you mentioned
ARDX is saying they will supply Xphozah free of charge to Medicare patients who lose coverage in Jan ...for the first 2 mths only
Nephrologists are probably already pulling back from starting Medicare
ARDX UNCY
SCAMBUSTERKING SCAMBUSTERKING 2 hours ago
My statements are backed up by the court docs filed by Jake and his lawyer... then even more proven by the actions of Jake.
BCAP
chereb19 chereb19 2 hours ago
An even bigger Whopper of a lie. Can't believe anything you write, there's are too many examples of your lies. Dishonest and incompetent?
RDGL
knrorrel knrorrel 2 hours ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
weedtrader420 weedtrader420 2 hours ago
☝️🤑☝️📈🚀
SUKUUSD
knrorrel knrorrel 2 hours ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
fuagf fuagf 2 hours ago
And all should understand subsidies discourage innovation leading to efficiency.
You're right too, we are talking about corporate farming in that respect also.
Ray_137 Ray_137 2 hours ago
That can be true plan 7 contains some parts of plan6. Investors in WAMU signed releases based on plan7.
COOP
Kam8 Kam8 2 hours ago
I am guessing $2+ after approval in UK, not only 27cents. 
NWBO
dstock07734 dstock07734 2 hours ago
George,

It could be none of them.
NWBO
snoopycomic snoopycomic 3 hours ago
Dufus- OS is the measurement.
NWBO

Your Recent History

NASDAQ
BLAC
Bellevue Life Sciences A...
BITMOT
3175939
Btpstripital Zc Jun25 Eur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved